HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments

SIMPLE SUMMARY: Since the advent of trastuzumab in HER2-positive metastatic breast cancer management, the natural history of this disease continues to improve. The development of molecular biology and better knowledge of the resistance mechanisms of cancer cells have enabled the development of sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Essadi, Ismail, Benbrahim, Zineb, Kaakoua, Mohamed, Reverdy, Thibaut, Corbaux, Pauline, Freyer, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046228/
https://www.ncbi.nlm.nih.gov/pubmed/36980624
http://dx.doi.org/10.3390/cancers15061738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046228/
https://www.ncbi.nlm.nih.gov/pubmed/36980624
http://dx.doi.org/10.3390/cancers15061738

Ejemplares similares